Blog

A new prognostic tool improves outcomes in liver cancer patients

A novel prognostic tool, the Weighted Alpha-Fetoprotein Tumor Burden Score (WATS), has demonstrated enhanced predictive capabilities for hepatocellular carcinoma patients post-resection. In a study involving 772 patients, WATS outperformed existing staging systems, offering reliable assessments of progression-free survival and overall survival across various time frames. Its formula incorporates tumor number, size, and alpha-fetoprotein levels, providing a significant advancement in patient stratification and clinical management, as evidenced by excellent discrimination and calibration results.

Journal Article by Lu T, Xie K (…) Xu F et 5 al. in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Postoperative C-reactive protein cut-off predicts complications.

A cut-off value of 114 mg/l for C-reactive protein on postoperative day three successfully predicts major complications in colorectal cancer patients, demonstrating a sensitivity of 80% and specificity of 59%. The study, involving 1,536 patients, found this threshold reliable across diverse subgroups, although specificity varied among certain demographics. Notably, elevated levels of CRP correlate with a significant 5.29-fold increase in the odds of major complications, suggesting its utility in early patient discharge decision-making.

Journal Article by Smit C, Janssen-Heijnen ML (…) Konsten JLM et 5 al. in Langenbecks Arch Surg

© 2025. The Author(s).

read the whole article in Langenbecks Arch Surg

open it in PubMed

1-mm CT outperforms 3-mm MRI in detecting lymph node metastasis

A study comparing 1-mm computed tomography (CT) and 3-mm magnetic resonance imaging (MRI) found that 1-mm CT significantly outperformed 3-mm MRI in detecting lateral pelvic lymph node (LPLN) metastases from rectal cancer. 1-mm CT detected LPLNs more frequently (p < 0.001), while the presence of swollen LPLNs indicated a 28.4% metastasis rate. Additionally, 3-mm MRI showed a 34% diagnostic performance increase for swollen LPLNs, suggesting a strategic evaluation approach for preoperative assessments.

Journal Article by Kobayashi R, Uehara K (…) Ajioka Y et 9 al. in Surg Today

© 2025. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

read the whole article in Surg Today

open it in PubMed

Unique barriers identified for marginalized HCC patients

Marginalized groups, particularly black patients and those affected by adverse social determinants of health, encounter significant barriers to curative treatments for hepatocellular carcinoma (HCC). Research revealed common challenges, such as information overload and communication gaps, while black patients also faced psychological burdens and systemic distrust. Conversely, patients experiencing adverse social determinants reported financial instability and care coordination difficulties. Solutions suggested by participants included enhanced education, communication strategies, and the establishment of peer support networks to facilitate access to treatment.

Journal Article by Nephew LD, Moore C (…) Rawl SM et 7 al. in Hepatol Commun

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.

read the whole article in Hepatol Commun

open it in PubMed

Surveillance offers lower stoma rates after local excision of rectal cancer.

A nationwide study involving 3057 patients revealed that after local excision of pT1-2 rectal cancer, locoregional recurrence (LR) rates were 14% for those undergoing surveillance compared to 4% after completion total mesorectal excision (CTME). Notably, 80% of patients with LR in the surveillance group were treated successfully. Furthermore, the risk of needing a stoma was significantly lower—4% after surveillance versus 43% after CTME. Overall disease-free and overall survival rates showed no significant difference.

Journal Article by Moolenaar LR, van Geffen EGM (…) Tuynman JB et 9 al. in Eur J Surg Oncol

Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Optimal interval for surgery after neoadjuvant therapy improves outcomes

A retrospective cohort study of 226 patients with locally advanced rectal cancer revealed that a 9-11 week interval between neoadjuvant chemoradiotherapy and surgery significantly increases the rates of pathological complete response (pcr). Analysis indicated that 10.5 weeks is optimal for maximizing pcr probabilities without raising postoperative risks. Multivariate logistic regression confirmed that this surgery interval is a significant predictor of pcr, allowing for improved treatment outcomes without additional complications.

Journal Article by Ahmadinejad M, Parvizi A (…) Ziaie S et 7 al. in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Patient satisfaction with implantable venous access ports is confirmed

Satisfaction with long-term totally implantable venous access ports (TIVAPs) was assessed in 149 cancer patients, showing non-inferiority to existing literature in overall satisfaction, willingness to choose the port again, cosmetic results, and pain experience. Complications were minimal, with 91.4% of catheter accesses complication-free. While satisfaction levels were adequate, no superiority in cosmetic outcomes was found compared to previous studies, indicating a reliable option for patients needing chemotherapy and parenteral nutrition.

Observational Study by Werba A, Hennes R (…) Pianka F et 8 al. in Langenbecks Arch Surg

© 2025. The Author(s).

read the whole article in Langenbecks Arch Surg

open it in PubMed

Multidisciplinary approaches improve pancreatic cancer management

Findings emphasize the need for multidisciplinary evaluations in pancreatic ductal adenocarcinoma (PDAC) management, with only 20% of patients eligible for curative surgery at diagnosis. Preoperative imaging techniques, particularly CT and EUS, are essential for accurate staging and vascular assessment. The review underscores the importance of tailored approaches across disease stages, including endoscopic drainage methods and systemic therapies, which collectively enhance patient outcomes and survival prospects through personalized care strategies.

Review by Mauro A, Faverio C (…) Anderloni A et 12 al. in J Clin Med

read the whole article in J Clin Med

open it in PubMed

New therapies improve survival rates for pancreatic cancer patients

Pancreatic cancer remains a leading global cause of death, exacerbated by aging demographics and rising risk factors like obesity and smoking. Despite its generally poor prognosis, advancements in treatment have emerged, particularly through neoadjuvant therapies, targeted therapies based on genetic testing, and immune checkpoint inhibitors. Minimally invasive surgical techniques have enhanced the safety and efficacy of surgical interventions, improving survival outcomes. A comprehensive review of these evolving treatments offers hope for better management of both localized and metastatic pancreatic cancer.

Review by Hayat U, Croce PS (…) Hanif A et 6 al. in J Clin Med

read the whole article in J Clin Med

open it in PubMed

Machine learning accurately predicts temporary stoma formation in CD patients

A machine learning model effectively predicts temporary stoma formation following intestinal resection in Crohn’s disease patients. An analysis of 252 patient records identified eight key predictors, achieving an area under the curve (AUC) between 0.886 and 0.998. The random forest algorithm showed the highest predictive accuracy, leading to potential improvements in surgical decision-making and personalized treatment approaches for patients. This innovative approach may enhance patient outcomes and streamline clinical processes for Crohn’s disease management.

Journal Article by Wang FT, Lin Y (…) Chen CQ et 6 al. in BMC Gastroenterol

© 2025. The Author(s).

read the whole article in BMC Gastroenterol

open it in PubMed